Clinical Trial

A New Cancer Rehabilitation Process for Chemotherapy-Induced Foot Neuropathy Using Orthopedic Devices

Study acronym: FOTNEV
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical study is to evaluate a new process for assessing and alleviating chemotherapy-induced peripheral neuropathy in the feet in patients treated with chemotherapy for early stage breast cancer. It will also compare two orthopedic interventions for symptom relief. The main questions it aims to answer are: Can an orthopedic silicone orthosis reduce chemotherapy-induced peripheral neuropathy symptoms in the feet? How does the effectiveness of the silicone orthosis compare to standard orthopedic treatment with insoles and shoes? Participants will: Use either a silicone orthosis or standard orthopedic treatment Have contact with the clinic for assessments and follow-ups Report their symptoms and functional improvements over time
Trial Details
NCT Number NCT06904989
Lead Sponsor Vastra Gotaland Region
Conditions Polyneuropathy, Breast Cancer
Enrollment 40 participants
Start Date 2024-12-01
Primary Completion 2025-06 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-04-01